![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetic Modeling and Simulation of
Intramuscular and Subcutaneous Ibalizumab Delivery
|
|
|
AIDS 2022 July 29- Aug 1 Montreal
K.-L. Kuo 1, Y. Lai 1, J. Boulos 2, M. Zogheib 2, M. Markowitz 3, P. Mesquita 2
1TaiMed Biologics, Taipei, Taiwan, 2Theratechnologies, Montreal, Canada, 3TaiMed Biologics, Irvine, United States
![0730221copy](../images/073022/073022-6/0730221copy.gif)
![0730222copy](../images/073022/073022-6/0730222copy.gif)
![0730223copy](../images/073022/073022-6/0730223copy.gif)
![0730224copy](../images/073022/073022-6/0730224copy.gif)
![0730225copy](../images/073022/073022-6/0730225copy.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|